Immunicum AB (publ) announced that Michael Oredsson has decided to resign his position as chairman and member of Immunicum’s Board of Directors, effective as of the Extraordinary General Meeting (EGM) that will be held on January 22, 2021. The Board has agreed to appoint Christine Lind, currently serving as board member, as interim chairman until the next Annual General Meeting (AGM), to be held on May 4, 2021.